Picomolar range high-affinity VHH antibodies (nanobodies) were sequenced directly from serum polyclonal antibodies for the first time in the world. This demonstrates that REpAb® is a viable orthogonal antibody discovery platform to directly sequence those highly potent and highly developable antibodies, which have gone through the natural selection and maturation processes of the immune system.
(PRWeb July 19, 2022)
Read the full story at https://www.prweb.com/releases/2022/7/prweb18786819.htm
For more information, please visit
https://www.prweb.com/releases/2022/7/prweb18786819.htm